Venofer® is indicated to treat iron deficiency anemia (IDA) in adult and pediatric patients (2 years and older) with chronic kidney disease (CKD)

  • Venofer® (iron sucrose) injection, USP is an intravenous (IV) form of iron, which is a key ingredient for making new red blood cells
    • Iron is also necessary for your bone marrow to build healthy new red blood cells and provide oxygen to your organs and tissues through hemoglobin
  • If you or your child has been prescribed Venofer, it’s based on your blood work, which shows how many red blood cells you have and whether you have enough iron in your blood cells
  • If you are iron deficient, raising your iron levels can help increase your hemoglobin levels
  • Treating your anemia may help prevent future health problems
    • Over time, untreated IDA can cause heart problems; if you already have heart problems, it can make those problems worse

Talk to your doctor. Only your doctor can decide if Venofer is right for you.

How you’ll know Venofer is working for you

Your doctor will be able to see how Venofer is working by reviewing your blood tests. There are 2 tests that your doctor will likely monitor along with your hemoglobin and red blood cell count:

  • Ferritin. This is a protein that contains stored iron.
  • Transferrin saturation (TSAT). Transferrin is a protein that takes the iron from the storage protein (ferritin), or the iron that you’re being treated with, and brings it to the bone marrow, where it is used to build healthy red blood cells.

Where and how you’ll receive Venofer

  • Venofer is given intravenously (through an IV) and administered at your doctor’s office or an infusion center
  • Depending on your doctor’s instructions and other treatments you receive, you will need to go back for several treatments with Venofer. Your doctor will go over your treatment schedule in further detail.

You Are Not Alone

The Venofer patient brochure provides information and support for CKD patients (2 years and older) with IDA.


*Patients are calculated based on an estimated annual cumulative dose. Data on file, American Regent, Inc.


1. IQVIA [NSP Audit from MAT November 2013 to November 2018].

Learn more about IDA in people with CKD